During the past decade, Hawaii Pacific Health conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hawaii Pacific Health" #1 sponsor was "Sequenom, Inc." with 2 trials, followed by "AstraZeneca" with 1 trials sponsored, "Frank C Sciurba" with 1 trials sponsored, "GlobeImmune" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hawaii Pacific Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hawaii Pacific Health" are "Down Syndrome" (2 trials), "Alzheimer's Disease" (1 trials), "Aneuploidy" (1 trials), "COVID-19" (1 trials) and "Collagen Disorders and/or Avascular Necrosis of the Femoral Condyle" (1 trials). Many other conditions were trialed in "Hawaii Pacific Health" in a lesser frequency.

Most popular intervention types in "Hawaii Pacific Health" are "Drug" (5 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apixaban 2.5 MG" (2 trials), "Apixaban 5MG" (1 trials), "Aspirin" (1 trials) and "GI-5005" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hawaii Pacific Health" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hawaii Pacific Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hawaii Pacific Health, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hawaii Pacific Health, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".